$0.9991
-0.02-2.05%
At close: -
$0.9991
0.000.00%
After Hours: Dec 20, 4:03 PM EDT
Ovid Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ovid Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.20 | $-0.19 | -5.26 % |
Jun 2024 | 2024-08-13 | $0.12 | $-0.22 | 154.6 % |
Mar 2024 | 2024-05-14 | $-0.17 | $-0.22 | 22.7 % |
Dec 2023 | 2024-03-08 | $-0.22 | $-0.05 | -340.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $173.00K | $87.14K | 98.5 % |
Jun 2024 | 2024-08-13 | $169.00K | $70.00K | 141.4 % |
Mar 2024 | 2024-05-14 | $148.00K | $60.00K | 146.7 % |
Sep 2023 | 2023-11-03 | $108.97K | $50.00K | 117.9 % |
Ovid Therapeutics (OVID) is scheduled to report earnings on March 7, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.20, which missed the estimate of $-0.19.
The Actual Revenue was $173K, which beat the estimate of $87.1K.
Browse earnings estimates, EPS, and revenue on all stocks.